Unknown

Dataset Information

Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.


ABSTRACT:

Background and objectives

Use of bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is controversial for diagnosing bone loss in CKD patients on dialysis. The alternative quantitative computed tomography (QCT) is expensive and requires high radiation exposure. This study compared the two techniques and evaluated serum biochemical parameters for prediction of bone loss.

Design, setting, participants, & measurements

This prospective study enrolled patients from dialysis centers throughout Kentucky. BMD of the spine and hip was measured at baseline and after 1 year by DXA and QCT. Customary and novel serum biochemical parameters were obtained at the same times, including calcium, phosphorus, whole and intact parathyroid hormone, bone-specific alkaline phosphat

SUBMITTER: Malluche HH 

PROVIDER: S-EPMC4078960 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature